According to a report, titled “Digital Pathology: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to grow due to the increasing number of people diagnosed with related diseases. The Global Digital Pathology Market is probably going to extend because of the rising utilization of cutting edge symptomatic instruments for a brief finding of interminable maladies.
Furthermore, the global digital pathology market is likely to grow in the forthcoming years due to recent technological advancements in pathology devices. Recent advancements have induced increasing operational efficacy, which is a major factor propelling growth in the global digital pathology market.
Get Sample PDF Brochure:
Digital pathology is applicable across diverse domains within the healthcare industry. This, as per Fortune Business Insights, is a chief driver of the global market. Digital pathology involves producing a clear predictive image using various imaging devices.
Moreover, these images can be shared or transferred through digital slides. A hospital, research laboratory and any related center can transfer the image anywhere in the world within no time. This significantly reduces the time to treat and diagnose and eliminates the need to call upon a specialist for a consultation. The aforementioned factors have created an increasing adoption of digital pathology over other methods.
In surgical pathology, the diagnosed tissue can be detected, diagnosed, treated, and then incised into paper thin slices. These slices are then mounted upon glass slides, which are then examined by pathologists under microscopic conditions. This method was a first of its kind and possesses very high efficiency, besides offering clear and sharp images. Furthermore, digital slides can be reproduced as many times as needed. Therefore, the use of pathology in surgical procedures ensures higher surgical efficiency and reduces the time required for diagnosis and operation. This has led to the rapid adoption of digital pathology around the world.
Some of the major companies that are present in the global digital pathology market are;
- 3DHistech, Inc.,
- ZIH Corp,
- Mikroscan Technologies, Inc.,
- Objective Pathology Services,
- Hamamatsu Photonics K.K.,
- Hoffmann-La Roche Ltd.,
- Primera Technology,
- CEREBRUM CORP,
- Nikon Corporation,
- Biogenuix, Indica Labs, Inc.,
- Koninklijke Philips N.V.,
- Sectra AB,
- Leica Biosystems Nussloch GmbH,
- Olympus Corporation, and others.
Browse Complete Report Details at
In April 2017, the FDA gave its approval to Philips’ Intellisite Pathology (PIPS) for manufacturing and sale in the U.S. This was the first ever digital pathology system in the market with FDA clearance. According to Fortune Business Insights, approval to Philips’ Intellisite will encourage other pathology device manufacturers to come up with their own patents and use PIPS as a reference. Secondly, pathologists and related clinical centers that had held off buying any type of pathology systems, until they would receive clearance from a regulatory authority, would now willingly invest and buy Philips’ Intellisite due to the FDA approval. Such factors will lead to the entry of newer market players and also encourage existing companies to improvise as well as improve their product to shake off competition from Philips.
Some of the major companies that are likely to contribute to the growth of the global digital pathology market are Digipath Inc., Hamamatsu Photonics K.K., Danaher Corporation, Koninklijke Philips N.V., Indica Labs, Inc., Nikon Corporation, Glencoe Software, Inc., PerkinElmer, Inc., Pixcelldata Ltd., and Visiopharm A/S., Leica Biosystems, 3DHISTECH, HCL Technologies, Ventana Medical Systems,Pathology Devices, Inc., OptraSCAN, Biogenous, Sectrae and Pathcore.